Trials / Active Not Recruiting
Active Not RecruitingNCT05096338
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
Cardiotoxicity of Prostate Cancer Therapy: Mechanisms, Predictors, and Social Determinants of Health in Prostate Cancer Patients Treated With Androgen Deprivation Therapy
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study for patients with prostate cancer that will be treated with Androgen Deprivation Therapy. The study will help the investigators learn more about how these medications affect the heart and how those effects relate to patients' medical history and social determinants of health (such as race, gender identity, education, occupation, access to health services and economic resources). Patients on this study will have echocardiograms, blood draws, and answer questions about their symptoms and activity level. Patients will be followed on this study for up to 5 years.
Detailed description
The investigators propose a prospective longitudinal cohort of prostate cancer patients treated with Androgen Deprivation Therapy (ADT) to determine the associations between social determinants of health (SDOH) and cardiotoxicity risk and to determine wither associations between SDOH and cardiotoxicity risk differs according to race. Patients will be followed with serial echo, blood draw, and surveys prior to start of ADT and then 6 months, 1 year, 2 years, 3 years, and 5 years after start of ADT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Social Determinants of Health | We will perform detailed phenotyping of Social Determinants of Health using the National Institute of Minority Health and Health Disparities PhenX SDOH toolkit at baseline. |
Timeline
- Start date
- 2021-10-27
- Primary completion
- 2029-11-01
- Completion
- 2029-11-01
- First posted
- 2021-10-27
- Last updated
- 2026-03-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05096338. Inclusion in this directory is not an endorsement.